abstract |
The present invention uses novel compounds that are thyroid receptor ligands, preferably antagonists, and the use of such compounds in the treatment of cardiac disorders and metabolic disorders such as arrhythmias, thyrotoxicosis, subclinical hyperthyroidism, and liver disease About the method. |